本文へスキップ

相互作用

Apalutamide + Brentuximab

重症度: 中等度

Apalutamide and Brentuximab: moderate interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Brentuximab vedotin releases the cytotoxic agent MMAE, which is a CYP3A4 substrate. Apalutamide is a strong CYP3A4 inducer and may lower MMAE exposure, potentially reducing antitumor efficacy.

この相互作用をわかりやすく説明すると

Apalutamide and Brentuximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Apalutamide belongs to Endocrine; Brentuximab belongs to Oncology.

エビデンスレベル: Low

なぜ起こるのか

Apalutamide induces CYP3A4, increasing metabolism of the released MMAE.

対処法

Monitor for reduced treatment response; consider an alternative to apalutamide if clinically feasible.

薬剤師に尋ねること

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、ApalutamideとBrentuximabの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を14日間無料でお試し。カード登録不要。

よくある質問

Can I take Apalutamide with Brentuximab?

MediHelp rates the interaction as moderate. Apalutamide and Brentuximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Brentuximab vedotin releases the cytotoxic agent MMAE, which is a CYP3A4 substrate. Apalutamide is a strong CYP3A4 inducer and may lower MMAE exposure, potentially reducing antitumor efficacy.

How serious is the interaction between Apalutamide and Brentuximab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced treatment response; consider an alternative to apalutamide if clinically feasible.

What other medicines interact with Brentuximab?

MediHelp also lists interactions of Brentuximab with, for example, Bleomycin, Dengue vaccine, Etrasimod. The full list is on the Brentuximab page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン